Aspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings, Inc. (ASBP) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ASBP · as of Jun 9, 2026
Key Statistics
Explore Aspire Biopharma Holdings, Inc. Data
asbp stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
asbp competitorsASBP
ANNA
BOCN
CAUD
CHAA
CSLMStock Performance
Full HistoryAbout Aspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship …
what is aspire biopharma holdings, inc. · asbp stock overview · aspire biopharma holdings, inc. company profile · who is aspire biopharma holdings, inc. ceo · asbp NASDAQ · aspire biopharma holdings, inc. headquarters · aspire biopharma holdings, inc. business segments
About Stock Overview & Key Data
Aspire Biopharma Holdings, Inc. (ASBP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 20, 2025. As of the latest trading session, ASBP stock price is $6.65, with a market capitalization of $767,224. The stock has returned -98.60% over the past 12 months and -95.80% year-to-date.
In fiscal year 2025, Aspire Biopharma Holdings, Inc. reported revenue of $6202.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Aspire Biopharma Holdings, Inc. (ASBP) stock price is $6.65. The stock is traded on NASDAQ under the ticker symbol ASBP. The 52-week range is $0.11 – $35.00.